source
- Alnylam lowers Amvuttra sales outlook amid waning demand, shares slideAlnylam released its second‑quarter earnings, highlighting a challenging year for the biotech firm. The report showed continued pressure on its product portfolio. The company cut its full‑year sal…
- GSK to invest up to $110 million in expanded AI drug-discovery partnership with Relation TherapeuticsGSK announced it will pay Relation Therapeutics up to $110 million to broaden their existing collaboration that uses artificial‑intelligence models to identify new drug candidates. The expanded ag…